Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

Buy-and-Bill

COVID-19

Case-Based Roundtable

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Perspectives in Dermatology

Polls

Editorial Advisory Board

Partners

Subscribe

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Articles

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

Dermatology Times' Sunday Crossword: April 20, 2025

Marie Bosslett is the assistant editor of 

 and joined the MJH Life Sciences team in October 2024. She attended Loyola University Maryland in Baltimore and earned a Bachelor of Arts in Communication with minors in marketing and writing. When she’s not writing, Marie enjoys going to concerts, reading on the beach, and spending time with friends and family.

In case you missed it, this week we had news about HyBryte's treatment success in CTCL patients, the impact of the COVID-19 pandemic on BCC surgeries, the FDA approval of dupilumab for H1 antihistamine-refractory CSU, and more.

The Weekly Roundup: April 14-18

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

The Rx Recap: April 13-19

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

An insightful Q & A video interview, delving deep into specific topics and therapeutic areas.

Gain valuable knowledge and unique perspectives from these expert discussions, keeping you at the forefront of the latest advancements in the field.


This news content has been independently developed and is not endorsed by the American Academy of Dermatology:

Lisa Swanson, MD, FAAD; Aaron Farberg, MD; James Song, MD, FAAD; Alexandra Golant, MD, and Jennifer Soung, MD, discuss how, advancing pediatric atopic dermatitis management faces challenges of treatment adherence and limited pediatric-specific therapies. Recent innovations include targeted biologics, patient education tools, and multidisciplinary approaches. Future directions emphasize personalized medicine, barrier repair technologies, and improved quality-of-life assessment tools tailored to children's unique needs.

Advancing Pediatric Atopic Dermatitis Care: Challenges, Innovations, and Future Directions

Medical experts Karan Lal, DO, MS, FAAD; Cheri Frey, MD; Corey Hartman, MD, FAAD; Sophia Reid, MD, and Cheryl Burgess, MD,

explain how laser therapy can effectively treat chronic skin conditions through targeted light exposure while emphasizing the importance of customized treatment protocols and combination approaches for optimal patient outcomes.

Advancing Care With Laser and Light-Based Technology in Dermatology

Gina Mangin, MPAS, PA-C, discusses how evaluating atopic dermatitis treatment success requires a comprehensive approach that combines developing personalized treatment plans, identifying individual triggers, and measuring outcomes through both clinical assessments and patient-reported improvements in symptoms and quality of life.

Navigating Atopic Dermatitis Complexities and the Role of Topical Therapies - Society of Dermatology Physician Assistants

Robert Casquejo, PA-C; Karan Lal, DO, MS, FAAD; Lisa Weiss, MMSc, PA-C; James Song, MD, FAAD, and Douglas DiRuggiero, examine how atopic dermatitis affects diverse patient populations through varied clinical presentations, psychosocial burdens, and health care delivery methods, including telemedicine.

Exploring the Comprehensive Care and Treatment of Atopic Dermatitis - Elevate Derm

Andrew Alexis, MD, MPH; Karan Lal, DO, MS, FAAD; James Song, MD; Lisa Swanson, MD, and Lisa Swanson, MD, address vitiligo management across adult and pediatric populations, examining treatment strategies, psychological support, emerging therapies like JAK inhibitors, and the critical importance of individualized care plans that consider disease characteristics, age-specific needs, and family education.

Navigating Expectations, Strategies, and Challenges in Vitiligo

Aaron Farberg, MD, discusses how red light therapy’s diverse applications in wound healing and aesthetic dermatology offer a noninvasive treatment option with promising outcomes across various medical and cosmetic fields.

Optimizing Photodynamic Therapy in Dermatology: Benefits of Red Light Therapy

Five experts delve into the multifaceted aspects of pediatric atopic dermatitis care including demographic variances to long-term safety and efficacy, comparative analyses, key takeaways from recent research, personalized approaches, and future research directions. Discover clinical insights into the role of ruxolitinib in addressing critical challenges and enhancing patient outcomes.

Pediatric Atopic Dermatitis Dialogues at AAD 2024

This series delves into the multifaceted landscape of atopic dermatitis (AD) care and treatment. Through interviews with 4 leading dermatologists, this series explores key benchmarks, emerging trends, personalized medicine approaches, long-term safety considerations, and the integration of novel therapies in the management of AD. 

Exploring the Multifaceted Landscape of Atopic Dermatitis Care at the 2024 AAD Meeting

An expert in dermatology introduces a video series program exploring cutting-edge treatments at the forefront of atopic dermatitis management, exploring innovative insights and research that will redefine dermatological care.

Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference

Experts in dermatology discuss key highlights, updates, and take-aways from the 2023 Science of Skincare Summit.

Hot Topics in Skincare from the Science of Skincare Summit 2023

Experts in dermatology discuss hot topics in skin care from AAD 2023 relating to skin renewal, photoprotection in patients with skin of color, next generation cleansing technologies, and the use of over the counter and prescription acne products.

Hot Topics in Skincare From AAD 2023

Experts in dermatology discuss the practical and clinical considerations in the management of Generalized Pustular Psoriasis; highlighting a recent treatment approval.

Expert Perspectives on Generalized Pustular Psoriasis